Seaport Therapeutics Appoints Dr. David Wheadon to Board of Directors
Key Highlights Seaport Therapeutics appoints Dr. David Wheadon to its Board of Directors. Dr. Wheadon has over three decades…
Browsing Tag
Daphne Zohar
3 posts
Seaport Therapeutics Expands Executive Team with Key Appointments
Key Highlights Antony Loebel, M.D., appointed as Chief Medical Officer and President of Clinical Development. Lana Gladstein, J.D.,…
PureTech Health Advances Strategic Initiatives, Launches Seaport Therapeutics
Key Highlights Seaport Therapeutics launches with $100M in Series A financing to develop neuropsychiatric medicines. Leadership Transition: Daphne Zohar steps…